Glycoconjugate vaccine strategies for protection against invasive Salmonella infections

References

• Ferreccio C, Levine MM, Manterola A, Rodriguez G, Rivara I, Prenzel I, et al. Benign bacteremia caused by Salmonella typhi and paratyphi in children younger than 2 years. J Pediatr 1984; 104:899 - 901; http://dx.doi.org/10.1016/S0022-3476(84)80492-8; PMID: 6427437
   PubMed Web of Science ®Google Scholar
• Owais A, Sultana S, Zaman U, Rizvi A, Zaidi AK. Incidence of typhoid bacteremia in infants and young children in southern coastal Pakistan. Pediatr Infect Dis J 2010; 29:1035 - 9; PMID: 21046701
   PubMed Web of Science ®Google Scholar
• Chiu CH, Chuang CH, Chiu S, Su LH, Lin TY. Salmonella enterica serotype Choleraesuis infections in pediatric patients. Pediatrics 2006; 117:e1193 - 6; http://dx.doi.org/10.1542/peds.2005-2251; PMID: 16717121
   PubMedGoogle Scholar
• Chiu CH, Wu TL, Su LH, Liu JW, Chu C. Fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis, Taiwan, 2000-2003. Emerg Infect Dis 2004; 10:1674 - 6; PMID: 15498176
   PubMed Web of Science ®Google Scholar
• Chiu S, Chiu CH, Lin TY. Salmonella enterica serotype Choleraesuis infection in a medical center in northern Taiwan. J Microbiol Immunol Infect 2004; 37:99 - 102; PMID: 15181491
   PubMedGoogle Scholar
• Kazemi M, Gumpert G, Marks MI. Clinical spectrum and carrier state of nontyphoidal salmonella infections in infants and children. Can Med Assoc J 1974; 110:1253 - 7; PMID: 4857958
   PubMed Web of Science ®Google Scholar
• Nelson SJ, Granoff D. Salmonella gastroenteritis in the first three months of life. A review of management and complications. Clin Pediatr (Phila) 1982; 21:709 - 12; http://dx.doi.org/10.1177/000992288202101201; PMID: 7140121
   PubMed Web of Science ®Google Scholar
• Kuppermann N. Occult bacteremia in young febrile children. Pediatr Clin North Am 1999; 46:1073 - 109; http://dx.doi.org/10.1016/S0031-3955(05)70176-0; PMID: 10629675
   PubMed Web of Science ®Google Scholar
• Vugia DJ, Samuel M, Farley MM, Marcus R, Shiferaw B, Shallow S, et al, Emerging Infections Program FoodNet Working Group. Invasive Salmonella infections in the United States, FoodNet, 1996-1999: incidence, serotype distribution, and outcome. Clin Infect Dis 2004; 38:Suppl 3 S149 - 56; http://dx.doi.org/10.1086/381581; PMID: 15095184
   PubMed Web of Science ®Google Scholar
• Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, Mwarumba S, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 2005; 352:39 - 47; http://dx.doi.org/10.1056/NEJMoa040275; PMID: 15635111
   PubMed Web of Science ®Google Scholar
• Kariuki S, Revathi G, Kariuki N, Kiiru J, Mwituria J, Muyodi J, et al. Invasive multidrug-resistant non-typhoidal Salmonella infections in Africa: zoonotic or anthroponotic transmission?. J Med Microbiol 2006; 55:585 - 91; http://dx.doi.org/10.1099/jmm.0.46375-0; PMID: 16585646
   PubMed Web of Science ®Google Scholar
• Kariuki S, Revathi G, Kariuki N, Kiiru J, Mwituria J, Hart CA. Characterisation of community acquired non-typhoidal Salmonella from bacteraemia and diarrhoeal infections in children admitted to hospital in Nairobi, Kenya. BMC Microbiol 2006; 6:101; http://dx.doi.org/10.1186/1471-2180-6-101; PMID: 17173674
   PubMed Web of Science ®Google Scholar
• Mandomando I, Macete E, Sigaúque B, Morais L, Quintó L, Sacarlal J, et al. Invasive non-typhoidal Salmonella in Mozambican children. Trop Med Int Health 2009; 14:1467 - 74; http://dx.doi.org/10.1111/j.1365-3156.2009.02399.x; PMID: 19793081
   PubMed Web of Science ®Google Scholar
• Walsh AL, Phiri AJ, Graham SM, Molyneux EM, Molyneux ME. Bacteremia in febrile Malawian children: clinical and microbiologic features. Pediatr Infect Dis J 2000; 19:312 - 8; http://dx.doi.org/10.1097/00006454-200004000-00010; PMID: 10783021
   PubMed Web of Science ®Google Scholar
• Enwere G, Biney E, Cheung YB, Zaman SM, Okoko B, Oluwalana C, et al. Epidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in The Gambia. Pediatr Infect Dis J 2006; 25:700 - 5; http://dx.doi.org/10.1097/01.inf.0000226839.30925.a5; PMID: 16874169
   PubMed Web of Science ®Google Scholar
• Tennant SM, Diallo S, Levy H, Livio S, Sow SO, Tapia M, et al. Identification by PCR of non-typhoidal Salmonella enterica serovars associated with invasive infections among febrile patients in Mali. PLoS Negl Trop Dis 2010; 4:e621; http://dx.doi.org/10.1371/journal.pntd.0000621; PMID: 20231882
   PubMed Web of Science ®Google Scholar
• Wilson RP, Winter SE, Spees AM, Winter MG, Nishimori JH, Sanchez JF, et al. The Vi capsular polysaccharide prevents complement receptor 3-mediated clearance of Salmonella enterica serotype Typhi. Infect Immun 2011; 79:830 - 7; http://dx.doi.org/10.1128/IAI.00961-10; PMID: 21098104
   PubMed Web of Science ®Google Scholar
• Robbins JD, Robbins JB. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi. J Infect Dis 1984; 150:436 - 49; http://dx.doi.org/10.1093/infdis/150.3.436; PMID: 6207249
   PubMed Web of Science ®Google Scholar
• Klugman KP, Koornhof HJ, Robbins JB, Le Cam NN. Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine 1996; 14:435 - 8; http://dx.doi.org/10.1016/0264-410X(95)00186-5; PMID: 8735556
   PubMed Web of Science ®Google Scholar
• Pollard AJ, Perrett KP, Beverley PC. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Nat Rev Immunol 2009; 9:213 - 20; http://dx.doi.org/10.1038/nri2494; PMID: 19214194
   PubMed Web of Science ®Google Scholar
• Szu SC, Taylor DN, Trofa AC, Clements JD, Shiloach J, Sadoff JC, et al. Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines. Infect Immun 1994; 62:4440 - 4; PMID: 7927707
   PubMed Web of Science ®Google Scholar
• Kossaczka Z, Lin FY, Ho VA, Thuy NT, Van Bay P, Thanh TC, et al. Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam. Infect Immun 1999; 67:5806 - 10; PMID: 10531232
   PubMed Web of Science ®Google Scholar
• Lin FY, Ho VA, Khiem HB, Trach DD, Bay PV, Thanh TC, et al. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med 2001; 344:1263 - 9; http://dx.doi.org/10.1056/NEJM200104263441701; PMID: 11320385
   PubMed Web of Science ®Google Scholar
• Mai NL, Phan VB, Vo AH, Tran CT, Lin FY, Bryla DA, et al. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children. N Engl J Med 2003; 349:1390 - 1; http://dx.doi.org/10.1056/NEJM200310023491423; PMID: 14523155
   PubMed Web of Science ®Google Scholar
• Canh DG, Lin FY, Thiem VD, Trach DD, Trong ND, Mao ND, et al. Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese children. Infect Immun 2004; 72:6586 - 8; http://dx.doi.org/10.1128/IAI.72.11.6586-6588.2004; PMID: 15501790
   PubMed Web of Science ®Google Scholar
• Thiem VD, Lin FY, Canh G, Son NH, Anh DD, Mao ND, et al. The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines. Clin Vaccine Immunol 2011; 18:730 - 5; http://dx.doi.org/10.1128/CVI.00532-10; PMID: 21411598
   PubMed Web of Science ®Google Scholar
• Cui C, Carbis R, An SJ, Jang H, Czerkinsky C, Szu SC, et al. Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphtheria toxoid conjugates. Clin Vaccine Immunol 2010; 17:73 - 9; http://dx.doi.org/10.1128/CVI.00266-09; PMID: 19889941
   PubMed Web of Science ®Google Scholar
• Micoli F, Rondini S, Pisoni I, Proietti D, Berti F, Costantino P, et al. Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi. Vaccine 2011; 29:712 - 20; http://dx.doi.org/10.1016/j.vaccine.2010.11.022; PMID: 21115057
   PubMed Web of Science ®Google Scholar
• van Damme P, Kafeja F, Anemona A, Basile V, Hilbert AK, De Coster I, et al. Safety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults. PLoS One 2011; 6:e25398; http://dx.doi.org/10.1371/journal.pone.0025398; PMID: 21980445
   PubMed Web of Science ®Google Scholar
• Shah N. Indian Vi conjugate typhoid vaccine: misleading claims. Indian Pediatr 2010; 47:447; http://dx.doi.org/10.1007/s13312-010-0068-4; PMID: 20519792
   PubMed Web of Science ®Google Scholar
• Shah NK. Indian conjugate Vi typhoid vaccine: do we have enough evidence?. Indian Pediatr 2009; 46:181 - 2; PMID: 19242041
   PubMed Web of Science ®Google Scholar
• Mathew JL. Conjugate typhoid vaccine(s) in the Indian context. Indian Pediatr 2009; 46:182 - 4; PMID: 19242042
   PubMed Web of Science ®Google Scholar
• Arya SC. Salmonella typhi Vi antigen-negative isolates in India and prophylactic typhoid immunization. Natl Med J India 2000; 13:220; PMID: 11002694
   PubMed Web of Science ®Google Scholar
• Arya SC. Efficacy of Vi polysaccharide vaccine against Salmonella typhi. Vaccine 1999; 17:1015 - 6; PMID: 10195609
   PubMed Web of Science ®Google Scholar
• Baker S, Sarwar Y, Aziz H, Haque A, Ali A, Dougan G, et al. Detection of Vi-negative Salmonella enterica serovar typhi in the peripheral blood of patients with typhoid fever in the Faisalabad region of Pakistan. J Clin Microbiol 2005; 43:4418 - 25; http://dx.doi.org/10.1128/JCM.43.9.4418-4425.2005; PMID: 16145086
   PubMed Web of Science ®Google Scholar
• Lindberg AA, Le Minor L. Serology of Salmonella. In: Bergan T, ed. Methods in Microbiology: Academic Press, 1984:1-141.
   Google Scholar
• Konadu E, Shiloach J, Bryla DA, Robbins JB, Szu SC. Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls. Infect Immun 1996; 64:2709 - 15; PMID: 8698499
   PubMed Web of Science ®Google Scholar
• Hellerqvist CG, Lindberg B, Samuelsson K, Lindberg AA. Structural studies on the O-specific side-chains of the cell-wall lipopolysaccharide from Salmonella parathyphi A var. durazzo. Acta Chem Scand 1971; 25:955 - 61; http://dx.doi.org/10.3891/acta.chem.scand.25-0955; PMID: 5117491
   PubMedGoogle Scholar
• Grimont PAD, Weill FX. Antigenic formulae of the Salmonella serovars. WHO Collaborating Centre for Reference and Research on Salmonella 2007:1-166.
   Google Scholar
• Slauch JM, Mahan MJ, Michetti P, Neutra MR, Mekalanos JJ. Acetylation (O-factor 5) affects the structural and immunological properties of Salmonella typhimurium lipopolysaccharide O antigen. Infect Immun 1995; 63:437 - 41; PMID: 7529745
   PubMed Web of Science ®Google Scholar
• Ronholm J, Zhang Z, Cao X, Lin M. Monoclonal antibodies to lipopolysaccharide antigens of Salmonella enterica serotype Typhimurium DT104. Hybridoma (Larchmt) 2011; 30:43 - 52; http://dx.doi.org/10.1089/hyb.2010.0066; PMID: 21466285
   PubMed Web of Science ®Google Scholar
• Heffernan EJ, Harwood J, Fierer J, Guiney D. The Salmonella typhimurium virulence plasmid complement resistance gene rck is homologous to a family of virulence-related outer membrane protein genes, including pagC and ail.. J Bacteriol 1992; 174:84 - 91; PMID: 1729227
   PubMed Web of Science ®Google Scholar
• Grossman N, Schmetz MA, Foulds J, Klima EN, Jimenez-Lucho VE, Leive LL, et al. Lipopolysaccharide size and distribution determine serum resistance in Salmonella montevideo. J Bacteriol 1987; 169:856 - 63; PMID: 2433267
   PubMed Web of Science ®Google Scholar
• Liang-Takasaki CJ, Grossman N, Leive L. Salmonellae activate complement differentially via the alternative pathway depending on the structure of their lipopolysaccharide O-antigen. J Immunol 1983; 130:1867 - 70; PMID: 6187823
   PubMed Web of Science ®Google Scholar
• Liang-Takasaki CJ, Saxén H, Mäkelä PH, Leive L. Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae.. Infect Immun 1983; 41:563 - 9; PMID: 6347890
   PubMed Web of Science ®Google Scholar
• Gondwe EN, Molyneux ME, Goodall M, Graham SM, Mastroeni P, Drayson MT, et al. Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans. Proc Natl Acad Sci U S A 2010; 107:3070 - 5; http://dx.doi.org/10.1073/pnas.0910497107; PMID: 20133627
   PubMed Web of Science ®Google Scholar
• MacLennan CA, Gondwe EN, Msefula CL, Kingsley RA, Thomson NR, White SA, et al. The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children. J Clin Invest 2008; 118:1553 - 62; http://dx.doi.org/10.1172/JCI33998; PMID: 18357343
   PubMed Web of Science ®Google Scholar
• Casadevall A, Pirofski LA. A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Adv Immunol 2006; 91:1 - 44; http://dx.doi.org/10.1016/S0065-2776(06)91001-3; PMID: 16938537
   PubMed Web of Science ®Google Scholar
• Colwell DE, Michalek SM, Briles DE, Jirillo E, McGhee JR. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium. J Immunol 1984; 133:950 - 7; PMID: 6203984
   PubMed Web of Science ®Google Scholar
• Carlin NI, Svenson SB, Lindberg AA. Role of monoclonal O-antigen antibody epitope specificity and isotype in protection against experimental mouse typhoid. Microb Pathog 1987; 2:171 - 83; http://dx.doi.org/10.1016/0882-4010(87)90019-2; PMID: 2467161
   PubMed Web of Science ®Google Scholar
• Michetti P, Mahan MJ, Slauch JM, Mekalanos JJ, Neutra MR. Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Infect Immun 1992; 60:1786 - 92; PMID: 1373399
   PubMed Web of Science ®Google Scholar
• Svenson SB, Lindberg AA. Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice. Infect Immun 1981; 32:490 - 6; PMID: 6166555
   PubMed Web of Science ®Google Scholar
• Svenson SB, Nurminen M, Lindberg AA. Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium. Infect Immun 1979; 25:863 - 72; PMID: 387597
   PubMed Web of Science ®Google Scholar
• MacLennan CA, Gilchrist JJ, Gordon MA, Cunningham AF, Cobbold M, Goodall M, et al. Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults. Science 2010; 328:508 - 12; http://dx.doi.org/10.1126/science.1180346; PMID: 20413503
   PubMed Web of Science ®Google Scholar
• Roantree RJ, Rantz LA. A Study of the Relationship of the Normal Bactericidal Activity of Human Serum to Bacterial Infection. J Clin Invest 1960; 39:72 - 81; http://dx.doi.org/10.1172/JCI104029; PMID: 16695824
   PubMed Web of Science ®Google Scholar
• Polish Typhoid Committee. Controlled field trials and laboratory studies on the effectiveness of typhoid vaccines in Poland, 1961-64. Bull World Health Organ 1966; 34:211 - 22; PMID: 5296128
   PubMed Web of Science ®Google Scholar
• Hejfec LBSL, Salmin LV, Lejtman MZ, Kuz’minova ML, Vasil’eva AV, Levina LA, et al. A controlled field trial and laboratory study of five typhoid vaccines in the USSR. Bull World Health Organ 1966; 34:321 - 39; PMID: 5296393
   PubMed Web of Science ®Google Scholar
• Simon R, Tennant SM, Wang JY, Schmidlein PJ, Lees A, Ernst RK, et al. Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis. Infect Immun 2011; 79:4240 - 9; http://dx.doi.org/10.1128/IAI.05484-11; PMID: 21807909
   PubMed Web of Science ®Google Scholar
• Watson DC, Robbins JB, Szu SC. Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine. Infect Immun 1992; 60:4679 - 86; PMID: 1383154
   PubMed Web of Science ®Google Scholar
• Jörbeck HJ, Svenson SB, Lindberg AA. Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit opsonizing antibodies that enhance phagocytosis. Infect Immun 1981; 32:497 - 502; PMID: 7019072
   PubMed Web of Science ®Google Scholar
• Konadu EY, Lin FY, Hó VA, Thuy NT, Van Bay P, Thanh TC, et al. Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam. Infect Immun 2000; 68:1529 - 34; http://dx.doi.org/10.1128/IAI.68.3.1529-1534.2000; PMID: 10678970
   PubMed Web of Science ®Google Scholar
• Tennant SM, Wang JY, Galen JE, Simon R, Pasetti MF, Gat O, et al. Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains. Infect Immun 2011; 79:4175 - 85; http://dx.doi.org/10.1128/IAI.05278-11; PMID: 21807911
   PubMed Web of Science ®Google Scholar
• Song L, Nakaar V, Kavita U, Price A, Huleatt J, Tang J, et al. Efficacious recombinant influenza vaccines produced by high yield bacterial expression: a solution to global pandemic and seasonal needs. PLoS One 2008; 3:e2257; http://dx.doi.org/10.1371/journal.pone.0002257; PMID: 18493310
   PubMed Web of Science ®Google Scholar